【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 17
1.2 List of Figures 23
2 Introduction 27
2.1 Related Reports 28
3 Disease Overview 29
3.1 Macular Degeneration Overview 29
3.1.1 Etiology and Pathophysiology 31
3.1.2 Classification 35
3.1.3 Symptoms and Diagnosis 37
3.2 Macular Edema Overview 40
3.2.1 Etiology and Pathophysiology 41
3.2.2 Classification 44
3.2.3 Symptoms and Diagnosis 45
4 Epidemiology – Macular Edema 48
4.1 Disease Background 48
4.2 Risk Factors and Comorbidities 48
4.3 Global Trends 49
4.3.1 US 50
4.3.2 5EU 50
4.3.3 Japan 51
4.4 Forecast Methodology 51
4.4.1 Sources Used 52
4.4.2 Sources Not Used 54
4.4.3 Forecast Assumptions and Methods — Diagnosed Prevalent Cases of Diabetes 55
4.4.4 Forecast Assumptions and Methods — Diagnosed Prevalent Cases of Diabetic Retinopathy 59
4.4.5 Forecast Assumptions and Methods – Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population 60
4.4.6 Forecast Assumptions and Methods – Total Prevalent Cases of ME following BRVO and CRVO 61
4.5 Epidemiological Forecast for Macular Edema (2013-2023) 62
4.5.1 Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population 62
4.5.2 Age-Specific Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population 64
4.5.3 Sex-Specific Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population 66
4.5.4 Total Prevalent Cases of ME Following BRVO 68
4.5.5 Age-Specific Total Prevalent Cases of ME Following BRVO 70
4.5.6 Sex-Specific Total Prevalent Cases of ME following BRVO 72
4.5.7 Total Prevalent Cases of ME Following CRVO 74
4.5.8 Age-Specific Total Prevalent Cases of ME Following CRVO 76
4.5.9 Sex-Specific Total Prevalent Cases of ME Following CRVO 78
4.6 Discussion 80
4.6.1 Epidemiological Forecast Insight 80
4.6.2 Limitations of the Analysis 81
4.6.3 Strengths of the Analysis 82
5 Epidemiology – Age-Related Macular Degeneration 83
5.1 Disease Background 83
5.2 Risk Factors and Comorbidities 84
5.3 Global Trends 85
5.3.1 US 85
5.3.2 5EU 86
5.3.3 Japan 86
5.4 Forecast Methodology 87
5.4.1 Sources Used 88
5.4.2 Forecast Assumptions and Methods 90
5.5 Epidemiological Forecast for AMD (2013-2023) 94
5.5.1 Total Prevalent Cases of AMD 94
5.5.2 Age-Specific Total Prevalent Cases of AMD 95
5.5.3 Sex-Specific Total Prevalent Cases of AMD 97
5.5.4 Age-Standardized Total Prevalence of AMD 99
5.5.5 Total Prevalent Cases of AMD by Stage 101
5.5.6 Total Prevalent Cases of Late AMD by Subtype 102
5.6 Discussion 104
5.6.1 Epidemiological Forecast Insight 104
5.6.2 Limitations of the Analysis 105
5.6.3 Strengths of the Analysis 106
6 Disease Management 107
6.1 Diagnosis and Treatment Overview 107
6.1.1 Macular Edema Diagnosis 107
6.1.2 Macular Degeneration Diagnosis 107
6.1.3 Treatment Guidelines and Leading Prescribed Drugs 108
6.1.4 Clinical Practice 110
6.2 US 123
6.3 France 127
6.4 Germany 130
6.5 Italy 133
6.6 Spain 136
6.7 UK 139
6.8 Japan 142
7 Competitive Assessment 145
7.1 Overview 145
7.2 Product Profiles – Major Brands 146
7.2.1 Lucentis (ranibizumab) 146
7.2.2 Eylea (aflibercept) 157
7.2.3 Avastin (bevacizumab) 168
7.2.4 Macugen (pegaptanib sodium) 175
7.2.5 Visudyne (verteporfin) 178
7.2.6 Corticosteroid Implants 183
8 Unmet Need and Opportunity 195
8.1 Overview 195
8.2 Treatment for Dry AMD 196
8.2.1 Unmet Need 196
8.2.2 Gap Analysis 198
8.2.3 Opportunity 200
8.3 Longer-Acting Anti-VEGF Drug Therapy 202
8.3.1 Unmet Need 202
8.3.2 Gap Analysis 204
8.3.3 Opportunity 204
8.4 Increased Efficacy of Anti-VEGF Therapy for wAMD 205
8.4.1 Unmet Need 205
8.4.2 Gap Analysis 206
8.4.3 Opportunity 207
8.5 Less Invasive Drug Formulations 207
8.5.1 Unmet Need 207
8.5.2 Gap Analysis 208
8.5.3 Opportunity 209
8.6 Awareness and Earlier Patient Diagnosis 210
8.6.1 Unmet Need 210
8.6.2 Gap Analysis 211
8.6.3 Opportunity 211
8.7 Home Monitoring of AMD Progression 212
8.7.1 Unmet Need 212
8.7.2 Gap Analysis 213
8.7.3 Opportunity 214
9 Pipeline Assessment 216
9.1 Overview 216
9.2 Clinical Trial Mapping 217
9.3 Promising Drugs in Clinical Development 218
9.3.1 Abicipar pegol 220
9.3.2 Fovista 227
9.3.3 Squalamine 235
9.3.4 Lampalizumab 243
9.3.5 Emixustat 250
9.3.6 Optina 257
9.3.7 DE-102 265
9.4 Promising Drugs in Early-Stage Development 269
9.4.1 Complement Inhibitors 269
9.5 Other Drugs in Development 271
9.6 Biosimilars 273
10 Current and Future Players 275
10.1 Overview 275
10.2 Trends in Corporate Strategy 277
10.3 Company Profiles 278
10.3.1 Roche/Genentech 278
10.3.2 Novartis 282
10.3.3 Regeneron 285
10.3.4 Bayer 289
10.3.5 Valeant 293
10.3.6 Allergan 296
10.3.7 Alimera Sciences 299
10.3.8 Ampio Pharmaceuticals 303
10.3.9 Ophthotech 305
10.3.10 Acucela 309
10.3.11 Ohr Pharmaceuticals 313
11 Market Outlook 316
11.1 Global Markets 316
11.1.1 Forecast 316
11.1.2 Drivers and Barriers – Global Issues 324
11.2 US 327
11.2.1 Forecast 327
11.2.2 Key Events 333
11.2.3 Drivers and Barriers 333
11.3 France 335
11.3.1 Forecast 335
11.3.2 Key Events 341
11.3.3 Drivers and Barriers 341
11.4 Germany 345
11.4.1 Forecast 345
11.4.2 Key Events 350
11.4.3 Drivers and Barriers 350
11.5 Italy 353
11.5.1 Forecast 353
11.5.2 Key Events 360
11.5.3 Drivers and Barriers 360
11.6 Spain 364
11.6.1 Forecast 364
11.6.2 Key Events 369
11.6.3 Drivers and Barriers 369
11.7 UK 372
11.7.1 Forecast 372
11.7.2 Key Events 378
11.7.3 Drivers and Barriers 378
11.8 Japan 382
11.8.1 Forecast 382
11.8.2 Key Events 388
11.8.3 Drivers and Barriers 388
12 Appendix 392
12.1 Bibliography 392
12.2 Abbreviations 427
12.3 Methodology 434
12.4 Forecasting Methodology 434
12.4.1 Diagnosed ME and AMD Patients 434
12.4.2 Percentage of Drug-Treated Patients 435
12.4.3 Drugs Included in Each Therapeutic Class 435
12.4.4 Launch and Patent Expiry Dates 435
12.4.5 General Pricing Assumptions 436
12.4.6 Individual Drug Assumptions 437
12.4.7 Pricing of Pipeline Agents 442
12.5 Primary Research – KOLs Interviewed for this Report 443
12.6 Primary Research – High-Prescribers Survey 444
12.7 About the Authors 445
12.7.1 Analyst 445
12.7.2 Therapy Area Director 445
12.7.3 Epidemiologist 446
12.7.4 Global Head of Healthcare 446
12.8 About GlobalData 447
12.9 Disclaimer 447
【レポート販売概要】
■ タイトル：黄斑浮腫・黄斑変性治療薬の世界市場予測および分析■ 英文：PharmaPoint: Macular Edema and Macular Degeneration - Global Drug Forecast and Market Analysis to 2023
■ 発行日：2014年10月31日
■ 調査会社：GlobalData
■ 商品コード：GDHC111PIDR
■ 調査対象地域：グローバル
- グローバル太陽光発電(PV)用バックシート市場（2014-2018）About Solar PV Backsheets A solar backsheet is used as the outer most layer of a solar PV module. It protects the inner components such as PV cells and electrical components. Due to their dielectric properties, backsheets can act as electric insulators for power-generating modules. TechNavio's analysts forecast the Global Solar PV Backsheet market will grow at a CAGR of 15 percent over the period …
- ネットワーク管理ソリューションの世界市場The network management market ecosystem encompasses industry players offering software, solutions and products, equipment vendors, third-party application vendors and system integrators. Prominent players in the network management market space are Cisco, Juniper Networks, IBM, HP, Dell, EMC, Brocade, and BMC Software amongst others. These companies play a critical role in simplifying network manag …
- Tanzania Electric Supply Company Limited：発電所及び企業SWTO分析2015Tanzania Electric Supply Company Limited - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (ass …
- 介護製品の世界市場：大人用おむつ、移動補助用具/在宅介護補助器具About geriatric care devices Geriatric care services involves holistic, client-centered approach for planning, professional assessment, supervision, coordination, and health care management and quality of life services for the elderly population (aged 65 years and above). The products used for geriatric care include mobility assisted devices such as wheelchairs, walkers, and adult diapers for easi …
- 世界における小型自動車用OE(メーカー純正部品)基礎ブレーキ装置市場（2008-2028）This latest just-auto report edition offers a global review of the OE foundation braking sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE foundation braking market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategi …
- 黒色腫の疫学的予測（～2023）EpiCast Report: Melanoma - Epidemiology Forecast to 2023 Summary Melanoma of the skin is a malignant neoplasm of melanocytes and is a significant source of morbidity and mortality worldwide. GlobalData epidemiologists forecast that the diagnosed prevalent cases of melanoma of the skin (all ages) in the 8MM will increase from 155,057 diagnosed prevalent cases in 2013 to 207,606 diagnosed prevalent …
- 教育用装置の世界市場：パソコン、タブレット、ディスプレイ、電子黒板、スタイラスペン、ワイヤレススレート、ウェアラブル端末、プロジェクター、サウンド装置About the Global Education Hardware Market Over the years, there has been a significant increase in the adoption of technology in the education sector globally. With an increase in investment by educational institutions to build IT infrastructure, there has been a noteworthy influence on the way education is imparted. As a result, the traditional classroom structure is gradually being replaced by …
- Ophthalmic Diagnostic Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018Ophthalmic Diagnostic Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalData’s new report, “Ophthalmic Diagnostic Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Ophthalmic Diagnostic Equipment market in the BRICS countries. The report provides value ($m), volume (units) and a …
- 化粧品用チューブ・瓶の世界市場2017-2021About Cosmetic Tubes and Jars Market The global cosmetics packaging market is the parent market of the global cosmetic tubes and jars market. Cosmetic packaging refers to the casing or the primary packaging of various cosmetic products such as color cosmetics, moisturizers, creams, shampoos, conditioners, hair colors, perfumes, deodorants, and other toiletries. The global cosmetics packaging marke …
- 世界のグリーン溶剤＆バイオ溶剤市場：乳酸塩エステル、アルコール、グリコールなどThe report covers the major Green Solvents and Bio Solvents markets including lactate esters, alcohols, glycols, diols, d-limonene, and methyl soyate solvents. It further divides the market on the basis of types, applications, and geography. The current major solvent types within this market are alcohols, glycols, and diols. The market data for these solvents types is given with respect to volume …
- Market Opportunity Service Delivery Platforms (SDP)Service Delivery Platform (SDP) can be loosely defined as a standards based framework that facilitates the design, development, implementation and management of services required to run the operations of network services providers. The services could range from the basic voice connectivity to the state-of-the-art rich multimedia services. SDP systems represent a cost effective, efficient choice fo …
- 季節性アレルギー性鼻炎(Seasonal Allergic Rhinitis)：世界の治験レビュー2014年下半期版Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2014" provides data on the Seasonal Allergic Rhinitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Seasonal Allergic Rhinitis. It includes an overview of the t …
- 船舶用風センサーの世界市場ABSTRACTAbout Marine Wind Sensor A marine wind sensor is a vital component of a boat. Most of the powerboats are equipped with a wind sensor, whereas yachts are generally equipped with multiple wind sensors to measure the wind speed and direction accurately. Technavio’s analysts forecast the global marine wind sensor market to grow at a CAGR of 3.89% during the period 2017-2021. [Covered in this r …
- Hi-Fi（ハイファイ）システムの世界市場：スピーカー、サウンドバー、ネットワークメディアプレイヤー、ブルーレイプレイヤー、DVDプレイヤー、ヘッドホンAccording to the MarketsandMarkets forecast, the Hi-Fi system market size, in terms of value, is expected to grow from USD 10.62 Billion in 2015 to USD 16.49 Billion by 2022, at a CAGR of 6.4% between 2016 and 2022. In the past few years, wireless devices have made its way across various audio products such as speakers & sound bars, headphones, network media players, and others. Traditionally, thi …
- 子ども向けエンターテイメントセンターの世界市場：訪問者層別（子供のいる家族（0-9）、子供のいる家族（9-12）、ティーンエイジャー（12-18）、ヤングアダルト（18-24）、大人（24歳以上））、施設のサイズ別（最大 5,000平方フィート、5,001から10,000平方フィート、10,001から20,000平方フィート、20,001から40,000平方フィート、1から10エーカー、10から30エーカー、および30エーカー以上）、収入源別（入場料金とチケットの販売、飲食料品、商品化、広告、その他）、アクティビティエリア別（アーケードスタジオ、ARおよびVRゲーミングゾーン、フィジカルプレイアクティビティ、スキル/コンペティションゲーム）Children entertainment centers are small outdoor or indoor enjoyment parks also known as amusement parks. These centers are specially marketed toward families with small children to teenagers, and often associated with a larger operational center such as a theme park. These centers offer a wide variety of entertainment activities for almost all age groups. The major activities include thrill rides …
